| HOME | MEETINGS | MEMBERSHIP | EXHIBITORS | AWARDS | INFO | NEWS | ABOUT US | CONTACT | SIGN IN |
ensuring knowledge, enhancing quality
A 'not-for-profit' organisation,
run for pharmaceutical analysts by pharmaceutical analysts
MEETINGS
Listed below are the future JPAG meetings and selected partner meetings.
For past meetings or info on invoices, venue, posters & CPD, see right.
For past meetings or info on invoices, venue, posters & CPD, see right.
Thursday 3rd December 2026
Regulatory Hot Topics XI
Royal Society of Chemistry, London
APS GB join JPAG at the 11th Regulatory Hot Topics symposium which will include an update on BP activities and specifically look at the BPs new radiopharmaceuticals guidance. The programme will cover a discussion of international reliance procedures by MHRA, various ICH updates from ongoing guideline revisions. We will catch up with CERSIs and AI, and the changing landscape for combination products due to changes in the medical device regulations.
As usual, the meeting will provide an excellent opportunity for dialogue, discussion and debate in an open forum and allows learning from expert speakers involved in the development of quality regulatory guidance and best practice.
The meeting is open to the submission of abstracts for posters in line with the above proposed key themes.
Speakers:
Dr Paul Dickinson - Founder and Chief Scientist, Seda Pharmaceutical Development Services
Dr Matt Heath - Innovation Specialist, MHRA
Steve Hoare - Standards & Regulatory Governance, MHRA
Dr Janine Jamieson - IPQ
Marine Joly Battaglini - PharmDev Consulting
Tasneem Keshavji - Head of International Recognition, MHRA
Abha Raveau-violette - Combination Products and Medical Devices Ltd
James Rickard - Chief Scientific Officer, Richmond Research Institute
Prof Walkiria Schlindwein - De Montfort University, Leicester
Dr Stuart Williams - Dove Analytics
Dr Christian Zeine - Scientific Affairs EMEA, USP
DETAILS AND REGISTRATION
Regulatory Hot Topics XI
Royal Society of Chemistry, London
APS GB join JPAG at the 11th Regulatory Hot Topics symposium which will include an update on BP activities and specifically look at the BPs new radiopharmaceuticals guidance. The programme will cover a discussion of international reliance procedures by MHRA, various ICH updates from ongoing guideline revisions. We will catch up with CERSIs and AI, and the changing landscape for combination products due to changes in the medical device regulations.
As usual, the meeting will provide an excellent opportunity for dialogue, discussion and debate in an open forum and allows learning from expert speakers involved in the development of quality regulatory guidance and best practice.
The meeting is open to the submission of abstracts for posters in line with the above proposed key themes.
Speakers:
Dr Paul Dickinson - Founder and Chief Scientist, Seda Pharmaceutical Development Services
Dr Matt Heath - Innovation Specialist, MHRA
Steve Hoare - Standards & Regulatory Governance, MHRA
Dr Janine Jamieson - IPQ
Marine Joly Battaglini - PharmDev Consulting
Tasneem Keshavji - Head of International Recognition, MHRA
Abha Raveau-violette - Combination Products and Medical Devices Ltd
James Rickard - Chief Scientific Officer, Richmond Research Institute
Prof Walkiria Schlindwein - De Montfort University, Leicester
Dr Stuart Williams - Dove Analytics
Dr Christian Zeine - Scientific Affairs EMEA, USP
DETAILS AND REGISTRATION
Thursday 21st January 2027
Advanced Dissolution
Royal Society of Chemistry, London
This event brings together scientists, analysts, and industry colleagues for a focused, one day exploration of advanced dissolution and its growing role in modern pharmaceutical development. It is a follow on from the Fundamentals event held in October 2025. As formulations become more complex and regulatory expectations evolve, dissolution has shifted from a simple quality test to a powerful, mechanistic tool for understanding drug performance.
This seminar creates space for sharing experiences, practical insight alongside open discussions. During the day, we aim to highlight new approaches, identify emerging challenges, and discuss the analytical strategies that will shape the next generation of oral medicines. The challenge for us all is: can a single test be sensitive enough to predict changes that may be of clinical relevance, whilst being robust enough to satisfy the needs of a quality control environment?
We're open for abstracts now for posters - deadline: 1-Jan-27 (posters).
Speakers:
Dr Hannah Batchelor - Strathclyde Institute of Pharmacy and Biomedical Sciences
Dr James Butler - Consultant, formerly GlaxoSmithKline
Dr Paul Dickinson - Founder and Chief Scientist, Seda Pharmaceutical Development Services
Dr James Mann - AstraZeneca
Dr Laura Mason - Upperton Pharma Solutions
Marta Nawrocka - Pharmaron
Kieran Smith - Biowaived
DETAILS AND REGISTRATION
Advanced Dissolution
Royal Society of Chemistry, London
This event brings together scientists, analysts, and industry colleagues for a focused, one day exploration of advanced dissolution and its growing role in modern pharmaceutical development. It is a follow on from the Fundamentals event held in October 2025. As formulations become more complex and regulatory expectations evolve, dissolution has shifted from a simple quality test to a powerful, mechanistic tool for understanding drug performance.
This seminar creates space for sharing experiences, practical insight alongside open discussions. During the day, we aim to highlight new approaches, identify emerging challenges, and discuss the analytical strategies that will shape the next generation of oral medicines. The challenge for us all is: can a single test be sensitive enough to predict changes that may be of clinical relevance, whilst being robust enough to satisfy the needs of a quality control environment?
We're open for abstracts now for posters - deadline: 1-Jan-27 (posters).
Speakers:
Dr Hannah Batchelor - Strathclyde Institute of Pharmacy and Biomedical Sciences
Dr James Butler - Consultant, formerly GlaxoSmithKline
Dr Paul Dickinson - Founder and Chief Scientist, Seda Pharmaceutical Development Services
Dr James Mann - AstraZeneca
Dr Laura Mason - Upperton Pharma Solutions
Marta Nawrocka - Pharmaron
Kieran Smith - Biowaived
DETAILS AND REGISTRATION
Thursday 30th September 2027
Foundations: Pharmaceutical Trace Analysis
Royal Society of Chemistry, London
Trace-level impurities can have a profound impact on patient safety, product quality, and regulatory approval, despite being present at extremely low concentrations. Join us for the next event in the JPAG Foundations series, designed for scientists who want to build a practical understanding of why and when trace analysis is required throughout pharmaceutical development. This introductory symposium will explore the regulatory and scientific drivers behind trace analysis, providing context for the control of impurities and contaminants that may arise from manufacturing processes, raw materials, packaging systems, or product degradation.
Learn from experts across industry and regulatory science as they introduce the key areas of trace analysis, including extractables and leachables, nitrosamines, potential mutagenic impurities, elemental impurities, residual solvents, and other low-level analytes of concern. Discover the analytical techniques that enable detection and quantification at trace levels, understand the challenges associated with method development and measurement reliability, and gain insight into how trace analysis supports risk assessment, product development, and regulatory compliance. Network with fellow scientists and leave equipped with a strong foundation in one of the most important and rapidly evolving areas of pharmaceutical analysis.
DETAILS AND REGISTRATION
Foundations: Pharmaceutical Trace Analysis
Royal Society of Chemistry, London
Trace-level impurities can have a profound impact on patient safety, product quality, and regulatory approval, despite being present at extremely low concentrations. Join us for the next event in the JPAG Foundations series, designed for scientists who want to build a practical understanding of why and when trace analysis is required throughout pharmaceutical development. This introductory symposium will explore the regulatory and scientific drivers behind trace analysis, providing context for the control of impurities and contaminants that may arise from manufacturing processes, raw materials, packaging systems, or product degradation.
Learn from experts across industry and regulatory science as they introduce the key areas of trace analysis, including extractables and leachables, nitrosamines, potential mutagenic impurities, elemental impurities, residual solvents, and other low-level analytes of concern. Discover the analytical techniques that enable detection and quantification at trace levels, understand the challenges associated with method development and measurement reliability, and gain insight into how trace analysis supports risk assessment, product development, and regulatory compliance. Network with fellow scientists and leave equipped with a strong foundation in one of the most important and rapidly evolving areas of pharmaceutical analysis.
DETAILS AND REGISTRATION
EXTERNAL EVENTS:
UK Clinical Pharmacy Association (UKCPA) EVENTS:
See www.ukclinicalpharmacy.org for details.
UK Clinical Pharmacy Association (UKCPA) EVENTS:
See www.ukclinicalpharmacy.org for details.
INTERESTED IN OUR EVENTS?
We will keep you informed...
We will keep you informed...
All JPAG-hosted meetings award 4 hours of CPD points.
INVOICES & RECEIPTS are available: Please see the e-mail you receive after registration.
LOOKING FOR YOUR EVENT TICKET? Please see the e-mail you receive after registration.
VENUE INFORMATION
PRESENTING A POSTER?
INVOICES & RECEIPTS are available: Please see the e-mail you receive after registration.
LOOKING FOR YOUR EVENT TICKET? Please see the e-mail you receive after registration.
VENUE INFORMATION
PRESENTING A POSTER?
We always seek feedback from delegates attending JPAG events through an Evaluation form.
A recent analysis of the results has shown that more than 95% of attendees thought that JPAG meetings were well planned, relevant and met their main objectives, and would recommend JPAG meetings to colleagues
TESTIMONIALS...
Very enjoyable and thought-provoking day; going away with plenty of notes and specific items for discussion.
Excellent meeting, challenging and thought provoking. The organisation was excellent, thanks to all the efforts that JPAG team have made.
I have not attended a bad JPAG meeting yet. They are really good value for money and I really love to get the presentations as PDFs
I did appreciate receiving the slides before, as then I could print them and make notes around them during the symposium.
Getting an industry perspective on this topic was most helpful.
Fantastic to hear from NHS speaker, provides real insight to patient/clinician considerations that we don't necessarily see in industry.
Hearing the information from the clinical setting side was very useful.
Well organized. This was an amazing session. Prior sharing of the presentation was a great add on!
The most useful aspect of the webinar was the variety in the presentations across industry and the regulators. Really good to review the presentations beforehand.
Good value, well organised symposium. Always useful for focused topics.
A very good day. Enjoyed getting to speak to the presenters to discuss current challenges in industry.
Very enjoyable and thought-provoking day; going away with plenty of notes and specific items for discussion.
Excellent meeting, challenging and thought provoking. The organisation was excellent, thanks to all the efforts that JPAG team have made.
I have not attended a bad JPAG meeting yet. They are really good value for money and I really love to get the presentations as PDFs
I did appreciate receiving the slides before, as then I could print them and make notes around them during the symposium.
Getting an industry perspective on this topic was most helpful.
Fantastic to hear from NHS speaker, provides real insight to patient/clinician considerations that we don't necessarily see in industry.
Hearing the information from the clinical setting side was very useful.
Well organized. This was an amazing session. Prior sharing of the presentation was a great add on!
The most useful aspect of the webinar was the variety in the presentations across industry and the regulators. Really good to review the presentations beforehand.
Good value, well organised symposium. Always useful for focused topics.
A very good day. Enjoyed getting to speak to the presenters to discuss current challenges in industry.
JPAG plans and delivers events that address all aspects of pharmaceutical analysis and related facets of medicine control & registration.
PAST MEETINGS
Delegates at a symposium held at the Royal Society of Chemistry
| Call us: | CONTACT US | Follow us: |     | Terms and Conditions Privacy Statement |
| Joint Pharmaceutical Analysis Group 2026 Website © and by Delta Consultancy Services |
|